# Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain

> **NCT02748395** · PHASE4 · WITHDRAWN · sponsor: **Temple University**

## Conditions studied

- Chronic Abdominal Wall Pain
- Abdominal Cutaneous Nerve Entrapment Syndrome

## Interventions

- **DRUG:** Triamcinolone
- **OTHER:** Placebo
- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT02748395
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-05
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No IRB approval
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02748395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02748395, "Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02748395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*